Concepedia

M.C. Cox

MC

Statistics

Publications

11

Citations

541

H-Index

10

Active since

2011

Affiliations

Loxo Oncology at Lilly (United States)(Current)

The University of Texas MD Anderson Cancer Center

Memorial Sloan Kettering Cancer Center

Massachusetts General Hospital

Rigshospitalet

M.C. Cox is an author at Loxo Oncology at Lilly (United States) specializing in medicine, pathology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2011–2024

11

Publications

11

Larotrectinib in adult patients with solid tumours: a multi-centre, open-label, phase I dose-escalation study

David S. Hong, Todd M. Bauer, J. Jack Lee et al. · Annals of Oncology · 2019 · 152 citations · Full text

A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome

Emma Benton, Siobhan Crichton, R. Talpur et al. · European Journal of Cancer · 2013 · 151 citations

, , +6

Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD

Fiona L. Dignan, Danielle Greenblatt, M.C. Cox et al. · Bone Marrow Transplantation · 2011 · 66 citations

, , +1

Larotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach

Ulrik Lassen, Catherine M. Albert, Shivaani Kummar et al. · Annals of Oncology · 2018 · 43 citations · Full text

Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion

Stefan Bielack, M.C. Cox, Michaela Nathrath et al. · Annals of Oncology · 2019 · 39 citations · Full text

1–5 of 11